BostInno - March M&A: Sovos makes another buy, biotech startup sold for $450M bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
MedCity News
Roivant extends AI drug discovery reach with $450M Silicon Therapeutics buyout
Roivant Sciences is expanding its drug discovery and design capabilities via a stock deal to acquire Silicon Therapeutics. The Boston startup uses physics-based modeling to simulate proteins and the small molecules that bind to them.
Shares0
Roivant Sciences has technology that uses computer modeling to design drugs that harness the body’s natural way of disposing of old or damaged proteins. On Friday, the company unveiled a $450 million acquisition that could expand that platform’s reach, giving Roivant the capability to design more types of small molecule drugs.